IRIS
TRIESTE, LEOPOLDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.621
EU - Europa 5.500
AS - Asia 4.557
SA - Sud America 882
AF - Africa 120
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 20
Totale 18.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.286
IT - Italia 1.779
SG - Singapore 1.699
RU - Federazione Russa 1.195
CN - Cina 1.119
GB - Regno Unito 737
BR - Brasile 679
VN - Vietnam 627
DE - Germania 441
UA - Ucraina 286
CA - Canada 238
HK - Hong Kong 234
FR - Francia 187
BD - Bangladesh 172
KR - Corea 161
DK - Danimarca 147
IN - India 138
NL - Olanda 108
SE - Svezia 106
FI - Finlandia 95
PL - Polonia 80
AR - Argentina 78
IE - Irlanda 74
MX - Messico 62
ES - Italia 60
JP - Giappone 58
TR - Turchia 56
ZA - Sudafrica 46
ID - Indonesia 42
EC - Ecuador 41
AU - Australia 38
BE - Belgio 34
IQ - Iraq 32
PH - Filippine 32
AT - Austria 30
PK - Pakistan 30
CO - Colombia 25
MY - Malesia 23
PT - Portogallo 22
CH - Svizzera 21
EU - Europa 20
IL - Israele 20
TW - Taiwan 19
LT - Lituania 15
TN - Tunisia 15
MA - Marocco 14
PY - Paraguay 14
RO - Romania 14
SA - Arabia Saudita 12
SK - Slovacchia (Repubblica Slovacca) 12
UZ - Uzbekistan 12
VE - Venezuela 12
CL - Cile 11
JO - Giordania 11
PE - Perù 11
KE - Kenya 8
AZ - Azerbaigian 7
SN - Senegal 7
AL - Albania 6
BG - Bulgaria 6
EG - Egitto 6
GR - Grecia 6
JM - Giamaica 6
LV - Lettonia 6
SY - Repubblica araba siriana 6
AE - Emirati Arabi Uniti 5
BY - Bielorussia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
IR - Iran 5
LU - Lussemburgo 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
NI - Nicaragua 4
SI - Slovenia 4
UY - Uruguay 4
AO - Angola 3
BO - Bolivia 3
DM - Dominica 3
NG - Nigeria 3
PS - Palestinian Territory 3
SR - Suriname 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
NO - Norvegia 2
Totale 18.718
Salva come PNG Salva come JPEG
Città #
Dallas 1.865
Singapore 923
Ashburn 526
San Jose 478
Beijing 422
Chandler 375
Woodbridge 342
Southend 341
Houston 268
Hong Kong 218
Pisa 218
Milan 211
Moscow 185
San Mateo 175
Ho Chi Minh City 171
Ann Arbor 170
Los Angeles 156
The Dalles 156
Rome 151
Jacksonville 142
New York 142
Fairfield 123
Hanoi 120
Dearborn 105
Seattle 101
Daejeon 97
Cambridge 90
Wilmington 90
Boardman 88
Falls Church 87
São Paulo 80
Hefei 77
Santa Clara 75
Beauharnois 70
Lauterbourg 69
Dublin 67
Warsaw 67
Dong Ket 65
Seoul 62
Stevenage 61
Portsmouth 59
Lawrence 55
Orem 54
Montreal 51
Brooklyn 49
Buffalo 49
Fremont 49
Denver 47
Florence 47
Tokyo 43
Chennai 42
London 42
Council Bluffs 41
Munich 41
Atlanta 40
Stockholm 38
Salerno 37
Helsinki 33
Bologna 32
Serra 31
Johannesburg 30
Poplar 30
Mexico City 29
Frankfurt am Main 28
Haiphong 28
Paris 27
Phoenix 27
Chicago 26
Figino 26
Buti 25
Montréal 25
Amsterdam 24
Redwood City 23
Ankara 22
Genoa 22
Toronto 22
Old Bridge 21
Lucca 20
Nuremberg 20
Boston 19
Ottawa 19
Turin 19
San Francisco 18
Mumbai 17
Rio de Janeiro 17
Da Nang 16
Naples 16
Dhaka 15
Guayaquil 15
Livorno 15
Querétaro 15
Quito 15
Trento 15
Vienna 15
Hamburg 14
Istanbul 14
Manchester 14
Tel Aviv 14
Charlotte 13
Shanghai 13
Totale 10.912
Salva come PNG Salva come JPEG
Nome #
Nutri-Score and Food Perception: Insights from an Italian Study 755
On Robots and Insurance 573
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 503
The Effect of using Serifs in Brand Names on Luxury Perception 498
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 400
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 374
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 371
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 363
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 322
How colour saturation accelerates purchase behaviour, and influences food choice: 318
A systematic literature review of the economic impact of ankylosing spondylitis 308
Is EEG Suitable for Marketing Research? A Systematic Review 301
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 294
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 293
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 291
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 289
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 288
Natural and man-made disasters: challenges and international perspectives for insurance 282
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 280
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 280
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 274
Assessing the value of the use of diagnostic technology: trade offs for GPs 273
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 268
Columbus' egg and the engineer's effect in forecasting solutions adoption 258
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 258
Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for Telehealth applications 256
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 255
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 255
Health information technologies in systemic lupus erythematosus: focus on patient assessment 253
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 248
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 247
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS) 246
Asessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary Data 246
Taste Your Consumer Audience. How Sensory Expertise Influences Food Choice 242
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 242
KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT 240
Conseguenze cliniche ed economiche dello switch ai biosimilari dell’Infliximab nei pazienti reumatologici in Toscana 238
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 236
Systemic vasculitis: how little we know about their societal and economic burden 236
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients’ care pathway 234
Management and Treatment of Type 1 And 2 Diabetes: State of Art 233
Raiders of Lost Value 222
Consideration on the Accuracy of Watch for Physical Activity Tracker 220
The definition of a new organizational, technology-based, integrated home care model 218
Cost analysis of technological vs. conventional upper limb rehabilitation for patients with neurological disorders: an Italian real-world data case study 217
Razionale e strumenti della valutazione economica in sanità 213
The cost of illness of ultra-rare Cryopyrin Associated Periodic Syndromes (CAPS) in Italy: Preliminary results from the Radicea project 212
P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study 212
The economic impact of gout: a systematic literature review 211
Food literacy and food purchase behaviour 211
Switching from infliximab‐originator to infliximab‐biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 208
The nature, causes, and effects of skepticism on technology diffusion 203
Natura e ruolo degli indicatori nella logistica farmaceutica 200
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 199
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 192
Innovazione tecnologica, dinamica del contesto economico e logistica in sanità 179
Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years 178
L’evoluzione della distribuzione del farmaco e dell'erogazione dei servizi in farmacia 178
Farmaci per le patologie autoimmuni. Traiettorie di trattamento nell’artrite reumatoide 176
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria 175
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 168
Finanziamenti pubblici 166
Valutazione dei risultati di una gara 166
Analysis and Synthesis in Information Processing and Knowledge Creation 162
EYE ON PACK. Visual search strategies in food choice 160
Le start up 160
Strumenti per favorire gli investimenti e la competitività delle imprese 157
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases 156
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 150
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 150
Propedeutica alle scienze Sperimentali. Introduzione al metodo scientifico e all'inferenza statistica. 149
Valutazione dell’attività di malattia nei periodi di interruzione del trattamento con farmaci biologici modificanti la malattia reumatica in pazienti con artrite reumatoide 142
Industria 4.0 e Digitalizzazione 123
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 115
Managing customization, brand consistency, and identity dynamic trade-offs: opportunities and chaos 95
null 63
Validazione degli algoritmi di selezione dei pazienti reumatologici nei database amministrativi toscani e traiettorie di aderenza ai farmaci biologici modificanti la malattia nell’artrite reumatoide 61
Nonlinear trade-offs in customer acquisition and retention 57
null 13
Totale 18.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.613
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 0 0 0 0 0 0 164
2021/2022745 23 141 29 50 9 15 96 159 56 70 31 66
2022/2023841 65 85 46 134 100 136 10 47 122 28 36 32
2023/2024465 43 18 61 22 18 62 51 38 7 26 29 90
2024/20253.729 66 86 245 184 272 264 565 871 307 171 467 231
2025/20269.349 504 1.192 1.623 1.203 1.001 594 1.003 405 503 560 391 370
Totale 18.858